A novel serum-based steroid-protein panels for differentiating ovarian cancer from non-malignant adnexal masses.

Cancer Cell Int · 2025 · PMC12625692 · PMID 41250090

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

After adjusting for age and menopause, 11OHT and 11KT remained significantly lower (p adj <0.001, 0.003, respectively), while T showed borderline significance (p adj =0.08).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.